Selective serotonin reuptake inhibitors vs atypical agent
Improvement in depression at 6‐12 weeks: HAM‐D score (continuous) · adults living with HIV and depression
1 finding from 1 review
- no estimate extracted1 study · 70 participantsLow
Findings
What do systematic reviews say?
4 questions · 4 findings · 1 reviews · Common Mental Disorders
No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 4 · 100%Moderate 0 · 0%High 0 · 0%
Selective serotonin reuptake inhibitors vs atypical agent
Improvement in depression at 6‐12 weeks: HAM‐D score (dichotomized) · adults living with HIV and depression
Selective serotonin reuptake inhibitor (SSRI) showed no clear difference in improvement in depression at 6‐12 weeks: HAM‐D score (dichotomized) compared with atypical agent (low certainty).
1 finding from 1 review
- RR 0.94 [0.79, 1.11]1 study · 70 participantsLow
Selective serotonin reuptake inhibitors vs atypical agent
Improvement in depression at 6‐12 weeks: CGI‐I (score of 1 or 2) · adults living with HIV and depression
Selective serotonin reuptake inhibitor (SSRI) showed no clear difference in improvement in depression at 6‐12 weeks: CGI‐I (score of 1 or 2) compared with atypical agent (low certainty).
1 finding from 1 review
- RR 0.78 [0.52, 1.17]1 study · 70 participantsLow
Selective serotonin reuptake inhibitors vs atypical agent
Dropout · adults living with HIV and depression
Selective serotonin reuptake inhibitor (SSRI) showed no clear difference in study dropouts at 6‐12 weeks compared with atypical agent (low certainty).
1 finding from 1 review
- RR 1.67 [0.43, 6.45]1 study · 70 participantsLow